Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation

Journal: Nature Communications

Published: 2020-07-03

DOI: 10.1038/s41467-020-16991-2

Affiliations: 16

Authors: 26

Go to article
Institutions Share
Biomedical Research Networking Center in Hepatic and Digestive Diseases (CIBEREHD), Spain 0.19
Center for Cooperative Research in Biosciences (CIC bioGUNE), Spain 0.15
University of Vermont (UVM), United States of America (USA) 0.13
University of Colorado Anschutz Medical Campus (CU Anschutz), United States of America (USA) 0.10
Instituto de Investigación Marqués de Valdecilla (IDIVAL), HUMV, Spain 0.08
Dartmouth College, United States of America (USA) 0.08
Alnylam Pharmaceuticals, Inc., United States of America (USA) 0.08
University of the Basque Country (UPV/EHU), Spain 0.06
BioCruces Health Research Institute, Spain 0.06
Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IP), Spain 0.04
Inflammation and Macrophage Plasticity Laboratory, CIC bioGUNE, Spain 0.02
Pakea Bizkaia, Spain 0.02
Ikerbasque - Basque Foundation for Science, Spain 0

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER